Welcome to LookChem.com Sign In|Join Free

CAS

  • or

639858-45-0

Post Buying Request

639858-45-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

639858-45-0 Usage

Uses

5-Amino-2,4-difluorobenzoic Acid is used in the preparation of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 639858-45-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,9,8,5 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 639858-45:
(8*6)+(7*3)+(6*9)+(5*8)+(4*5)+(3*8)+(2*4)+(1*5)=220
220 % 10 = 0
So 639858-45-0 is a valid CAS Registry Number.

639858-45-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-amino-2,4-difluorobenzoic acid

1.2 Other means of identification

Product number -
Other names Benzoic acid,5-amino-2,4-difluoro

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:639858-45-0 SDS

639858-45-0Relevant articles and documents

Pyrrolotriazine kinase inhibitors

-

Page/Page column 13, (2010/02/15)

The present invention provides compounds of formula I, and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1, thereby making them useful as anti-ca

Heterocyclic inhibitors of kinases

-

Page/Page column 9, (2008/06/13)

The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 639858-45-0